B3UEZ6 (B3UEZ6_9HIV1) Human immunodeficiency virus 1
Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling
860 aa; Sequence (Fasta)
No models have been built for this target sequence.
Available Structures
14 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 |
Heteromer B3UES2; | 21×NAG; 9×NAG; 3×NAG; 33×NAG; | ||||
| Assess | ||||||
| Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM |
Heteromer B3UES2; P01730; | 16×NAG; 10×NAG; 2×NAG; 4×NAG; 1×NAG; 3×LMT; 24×NAG; | ||||
| Assess | ||||||
| Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM |
Heteromer B3UES2; P01730; | 24×NAG; 3×NAG; 3×NAG; 18×NAG; 3×LMT; | ||||
| Assess | ||||||
| Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding var… |
Heteromer B3UES2; P01730; | 12×NAG; 12×NAG; 3×NAG; 6×NAG; 24×NAG; | ||||
| Assess | ||||||
| Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 |
Heteromer B3UES2; P01730; | 3×NAG; 3×NAG; 27×NAG; 3×UOV; | ||||
| Assess | ||||||
| Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 |
Heteromer B3UES2; P01730; | 3×NAG; 1×NAG; 23×NAG; 3×UOV; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry I… |
Heteromer B3UES2; | 3×NAG; 6×NAG; 3×NAG; 42×NAG; 3×JYS; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H10… |
Heteromer B3UES2; | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 33×NAG; | ||||
| Assess | ||||||
| Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with th… |
Heteromer B3UES2; | 21×NAG; 6×NAG; 9×NAG; 6×NAG; 3×NAG; 12×NAG; | ||||
| Assess | ||||||
| B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 |
Heteromer B3UES2; Q8N5F4; S6B291; | 1×NAG; 3×NAG; 5×NAG; 15×NAG; 6×NAG; 1×NAG; 33×NAG; | ||||
| Assess | ||||||
| CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG |
Heteromer B3UES2; P01730; | 24×NAG; 3×NAG; 9×NAG; | ||||
| Assess | ||||||
| CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 |
Heteromer B3UES2; P01730; | 3×NAG; 3×NAG; 27×NAG; 3×N07; | ||||
| Assess | ||||||
| HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B |
Heteromer B3UES2; | 33×NAG; 3×NAG; 3×NAG; 30×NAG; | ||||
| Assess | ||||||
| B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the b… |
Heteromer B3UES2; P01730; | 15×NAG; 6×NAG; 3×NAG; 3×NAG; 27×NAG; | ||||
| Assess | ||||||